Sagimet Biosciences (NASDAQ:SGMT) Earns Buy Rating from HC W

HC Wainwright reaffirmed their buy rating on shares of Sagimet Biosciences (NASDAQ:SGMT – Free Report) in a research report released on Friday morning, Benzinga reports. The brokerage currently has a $32.00 target price on the stock. Several other brokerages also recently issued reports on SGMT. Leerink Partnrs reissued an outperform rating on shares of Sagimet […]

Related Keywords

United States , New York , American , Sagimet Biosciences , Leerink Partnrs , David Happel , Goldman Sachs Group , Securities Exchange Commission , Shaughnessy Asset Management , Sagimet Biosciences Company Profile , Sagimet Biosciences Inc , American International Group Inc , York State Common Retirement Fund , Pricet Rowe Associates Inc , Victory Capital Management Inc , Free Report , Exchange Commission , International Group , Victory Capital Management , Get Free Report , Biosciences Inc , Sagimet Biosciences Daily ,